Difference between revisions of "Filanesib (ARRY-520)"
Jump to navigation
Jump to search
m |
m |
||
| Line 6: | Line 6: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
| − | + | [[Category:Intravenous medications]] | |
[[Category:KSP inhibitors]] | [[Category:KSP inhibitors]] | ||
[[Category:Investigational drugs]] | [[Category:Investigational drugs]] | ||
| + | [[Category:Stub]] | ||
Revision as of 23:18, 23 February 2021
Mechanism of action
From the NCI Drug Dictionary: A synthetic, small molecule targeting the kinesin spindle protein (KSP) with potential antineoplastic activity. KSP inhibitor ARRY-520 specifically inhibits KSP (kinesin-5 or Eg5), resulting in activation of the spindle assembly checkpoint, induction of cell cycle arrest during the mitotic phase, and consequently cell death in tumor cells that are actively dividing.
Also known as
- Code name: ARRY-520